A network of experts in reproductive and children’s environmental health

PEHSU Grand Rounds Webinar

This webinar is part of an ongoing series of educational presentations by experts on issues that focus on current and emerging aspects of pediatric and reproductive environmental health.

DC Park Prescription: A Scalable Model for Medicine & Public Health - January 18, 2017

These presentations focus on the impact of environmental exposures to chemicals on human health at the vulnerable stages of in utero and pediatric development. A number of topics will be included – all of them relevant to questions of exposure and health effects, with consideration of risk reduction. Speakers will include physicians and PhD subject matter experts, as well as individuals with expertise in areas such as home assessment, laboratory analysis, and risk communication.

Learning Objectives

By the end of this module, participants should be able to:
  • Review health reasons to spend time in Nature
  • Learn how DC Park Rx was planned, developed and implemented at a "doctor's office"
  • Review recently published data on DC Park Rx
  • Summarize next steps for expansion and research of Park Rx 

Presenter: Robert Zarr, MD, MPH

Robert Zarr, MD, MPH
Park Rx Director, Unity Health Care, Inc.
National Park Rx Advisor, National Park Service
PEHSU Region 3 


Dr. Zarr is a board-certified public health pediatrician who trained at the University of Texas School of Public Health, Baylor College of Medicine and Texas Children’s Hospital. He is staff at Unity Health Care, faculty at Children’s National Medical Center and George Washington University’s School of Medicine.  He serves as Past President of the American Academy of Pediatrics DC Chapter, immediate President of Physicians for a National Health Program, and is founder and director of DC Park Prescription


Registration Information

Date and Time:
Wednesday, January 18, 2017 1:00 pm, Eastern Daylight Time (New York)
Wednesday, January 18, 2017 12:00 pm, Central Daylight Time (Chicago)
Wednesday, January 18, 2017 11:00 am, Mountain Daylight Time (Denver)
Wednesday, January 18, 2017 10:00 am, Pacific Daylight Time (San Francisco)

Register Button

Continuing Education Information Coming Soon


This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: 1U61TS000237-03 from the Agency for Toxic Substances and Disease Registry (ATSDR).

Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Charles A. McKay and he wishes to disclose that he is a member of the Scientific Advisory Council, Environmental Health Research Foundation (EHRF). EHRF addresses issues related to biomonitoring, a topic that is also relevant to some of the activities in the Grand Round Series that might be discussed in future sessions. EHRF receives funding from sources that includes industry. Dr. McKay has reviewed and written material for EHRF, that could create a perceived conflict of interest regarding environmental chemical exposure assessment/measurement.

Planning committee discussed conflict of interest with Dr. Charles A. McKay to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC does not accept commercial support.